Table 2.
Albumin prescriptions across various services and the number of prescriptions considered inappropriate within each service (N = 1,361)
| Service* | n (%) | |
|---|---|---|
| Albumin prescriptions per service | Inappropriate prescriptions† | |
| Solid tumours | 733 (29.5) | 299 (40.8) |
| Nephrology | 537 (21.6) | 31 (5.8) |
| Critical care | 452 (18.2) | 58 (12.8) |
| Outpatient | 354 (14.2) | 189 (53.3) |
| Palliative | 134 (5.4) | 58 (43.2) |
| Surgical | 128 (5.2) | 84 (65.6) |
| Lymphoma | 38 (1.5) | 13 (34.2) |
| Leukaemia | 23 (0.9) | 9 (39.1) |
*
Refers to the clinical service that prescribed albumin for the patient, regardless of the patient’s type of malignancy or hospital location.
†
The percentage of inappropriate prescriptions compared to the total number of prescriptions within the same service.